Shree Ganesh Remedies made a winning bid of Rs 26 crore for Jaiswal Pharmachem's 20,100 sq. m. plot in Ankleshwar, Gujarat.
The company is declared as the highest bidder with Rs 26 crore bid, for the e-auction of assets of Jaiswal Pharmachem, i.e., Plot No 6002 and 6003, GIDC Estate, Ankleshwar (land area approx. 20,100 sq. m.) (Gujarat).
The net profit of Shree Ganesh Remedies surged 51.62% to Rs 4.20 crore in the quarter ended December 2021 as against Rs 2.77 crore during the previous quarter ended December 2020. Net sales jumped 59.35% to Rs 21.13 crore in the quarter ended December 2021 as against Rs 13.26 crore during the previous quarter ended December 2020.
Shares of Shree Ganesh Remedies rose 1.28% to close at Rs 281.75 on BSE on Friday, 11 March 2022.
Shree Ganesh Remedies is an Indian pharmaceuticals company. Its core activities consist of manufacturing & export of pharmaceutical intermediates & fine chemicals and research & development.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
